Our study disclosed the guiding significance of SPNS expression in prognosis of AML, high expression of SPNS2 and SPNS3 were poor prognosis in chemotherapy patients, and SPNS3 was a poor indicator for OS in allo-HSCT patients. The gene discussed is SPNS3; the disease is acute myeloid leukemia.